COVID-19 Sinopharm Vaccine
Sinopharm is authorised by the World Health Organization (WHO) for its emergency use listing, and received WHO validation for its safety, efficacy and quality.
The Sinopharm vaccine provides an alternative option for people in Singapore. This is in line with efforts to enhance vaccination coverage against COVID-19 in Singapore.
Thomson Wellth Clinic has been approved by the Health Sciences Authority of Singapore to import the Sinopharm COVID-19 vaccine under the Special Access Route (SAR). You may now register for your interest at our clinic, via the online form below.
Who is eligible for the Sinopharm vaccine?
The Sinopharm vaccine comprises 2 doses，administered with an interval of 3 weeks, and is eligible for individuals who fulfill the following requirement:
- Above 18 years old
Guidelines on the Sinopharm vaccine:
The World Health Organisation (WHO) and the Strategic Advisory Group of Experts (SAGE) on Immunisation have also recommended that immunocompromised people, including those over 60 years of age, be given a third dose of Sinopharm or Sinovac vaccine, due to their higher risk of breakthrough infections after standard immunisation. The third dose of the Sinopharm or Sinovac vaccine should be received one to three months after completion of the two doses.
免疫功能较低者，包括60岁以上者， 由于他们的风险较高， 即使接种两剂疫苗后， 也较容易受冠状病毒突破性感染。因此世界卫生组织(WHO)和免疫战略咨询专家组(SAGE)也建议免疫功能较低者，包括60岁以上者，应接种第三剂国药或科兴疫苗。第三剂国药或科兴疫苗应在两剂国药或科兴疫苗完成后的第一到三个月内接种。
Register your interest in the Sinopharm vaccine here
Kindly note that completion of the form does not guarantee an appointment slot for the Sinopharm vaccine. Our clinic staff will contact you to confirm your appointment.